Cite
Vogels CBF, Watkins AE, Harden CA, et al. SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity. Med (N Y). 2020;2(3):263-280.e6doi: 10.1016/j.medj.2020.12.010.
Vogels, C. B. F., Watkins, A. E., Harden, C. A., Brackney, D. E., Shafer, J., Wang, J., Caraballo, C., Kalinich, C. C., Ott, I. M., Fauver, J. R., Kudo, E., Lu, P., Venkataraman, A., Tokuyama, M., Moore, A. J., Muenker, M. C., Casanovas-Massana, A., Fournier, J., Bermejo, S., Campbell, M., Datta, R., Nelson, A., Dela Cruz, C. S., Ko, A. I., Iwasaki, A., Krumholz, H. M., Matheus, J. D., Hui, P., Liu, C., Farhadian, S. F., Sikka, R., Wyllie, A. L., & Grubaugh, N. D. (2021). SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity. Med (New York, N.Y.), 2(3), 263-280.e6. https://doi.org/10.1016/j.medj.2020.12.010
Vogels, Chantal B F, et al. "SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity." Med (New York, N.Y.) vol. 2,3 (2021): 263-280.e6. doi: https://doi.org/10.1016/j.medj.2020.12.010
Vogels CBF, Watkins AE, Harden CA, Brackney DE, Shafer J, Wang J, Caraballo C, Kalinich CC, Ott IM, Fauver JR, Kudo E, Lu P, Venkataraman A, Tokuyama M, Moore AJ, Muenker MC, Casanovas-Massana A, Fournier J, Bermejo S, Campbell M, Datta R, Nelson A, Dela Cruz CS, Ko AI, Iwasaki A, Krumholz HM, Matheus JD, Hui P, Liu C, Farhadian SF, Sikka R, Wyllie AL, Grubaugh ND. SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity. Med (N Y). 2021 Mar 12;2(3):263-280.e6. doi: 10.1016/j.medj.2020.12.010. Epub 2020 Dec 26. PMID: 33521748; PMCID: PMC7836249.
Copy
Download .nbib